Overview

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
An open label, bioequivalence study of sumatriptan succinate 100 mg tablets (containing 140 mg of sumatriptan succinate equivalent to 100 mg sumatriptan) under fasting Conditions
Phase:
N/A
Details
Lead Sponsor:
Ranbaxy Laboratories Limited
Treatments:
Sumatriptan